(Q34088152)

30 July 2017

1 reference

title

Biochemical markers in breast cancer: which ones are clinically useful? (English)

1 reference

30 July 2017

1 reference

Duffy MJ

1

1 reference

30 July 2017

publication date

1 July 2001

1 reference

30 July 2017

published in

Clinical Biochemistry

1 reference

30 July 2017

volume

34

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

347-352

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Breast cancer genes and DNA repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Identification of the breast cancer susceptibility gene BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Pathological prognostic factors in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

7 January 2021

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Effect of axillary nodal status on the long-term survival following mastectomy for breast carcinoma: nodal metastases may not always suggest systemic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Cellular oncogenes and suppressor genes as prognostic markers in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

The urokinase-type plasminogen activator system in cancer metastasis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

The value of estrogen and progesterone receptors in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

HER-2/neu as a predictive marker of response to breast cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Tumour marker measurements in the diagnosis and monitoring of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

Prolonged survival by 'early' salvage treatment of breast cancer patients: a retrospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900201-0

10.1016/S0009-9120(00)00201-0

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference